Michael Monsour
Président chez ANALYTICA
Postes actifs de Michael Monsour
Sociétés | Poste | Début | Fin |
---|---|---|---|
ANALYTICA | Président | 22/06/2011 | - |
Australian Technology Innovation Fund Ltd.
Australian Technology Innovation Fund Ltd. Financial ConglomeratesFinance Australian Technology Innovation Fund Ltd. is an investment company that is not classified elsewhere. | Directeur/Membre du Conseil | - | - |
Godbar Software | Corporate Officer/Principal | 22/06/2011 | - |
Historique de carrière de Michael Monsour
Anciens postes connus de Michael Monsour
Sociétés | Poste | Début | Fin |
---|---|---|---|
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Directeur/Membre du Conseil | 31/01/2007 | 04/11/2011 |
Président | 04/11/2011 | 29/11/2011 | |
Hospira Adelaide Pty Ltd.
Hospira Adelaide Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Hospira Adelaide Pty Ltd. engages in the provision of biotechnology and research services. It also develops cell therapy technology. It offers biopharmaceutical API products including hGH, a treatment for human growth hormone deficiency; G-CSF, which is used in the treatment of leukemia; and Interferon alpha for chronic hepatitis B and C. The company was founded in 1982 and is headquartered in Thebarton, Australia. | Directeur/Membre du Conseil | 01/07/2005 | 16/09/2006 |
Vapotronics, Inc.
Vapotronics, Inc. Medical SpecialtiesHealth Technology Vapotronics, Inc. develops inhalation drug products. The company is headquartered in South Brisbane, Australia. | Président | - | - |
Formation de Michael Monsour
The University of Queensland | Undergraduate Degree |
Statistiques
Internationale
Australie | 8 |
Opérationnelle
Director/Board Member | 3 |
Chairman | 3 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 6 |
---|---|
Hospira Adelaide Pty Ltd.
Hospira Adelaide Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Hospira Adelaide Pty Ltd. engages in the provision of biotechnology and research services. It also develops cell therapy technology. It offers biopharmaceutical API products including hGH, a treatment for human growth hormone deficiency; G-CSF, which is used in the treatment of leukemia; and Interferon alpha for chronic hepatitis B and C. The company was founded in 1982 and is headquartered in Thebarton, Australia. | Commercial Services |
Vapotronics, Inc.
Vapotronics, Inc. Medical SpecialtiesHealth Technology Vapotronics, Inc. develops inhalation drug products. The company is headquartered in South Brisbane, Australia. | Health Technology |
Analytica Ltd.
Analytica Ltd. Medical SpecialtiesHealth Technology Analytica Ltd. engages in the design development, and supply of class 1 and class 2 medical devices. It operates through the following segment: Medical Devices and Corporate. The Medical Devices segment is consist of AutoStart Burette, PeriCoach, and ELF 2. The Corporate segment includes all other operations including the administration, and associated listed public company expenditure. The company is headquartered in Brisbane, Australia. | Health Technology |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Health Technology |
Godbar Software | |
Australian Technology Innovation Fund Ltd.
Australian Technology Innovation Fund Ltd. Financial ConglomeratesFinance Australian Technology Innovation Fund Ltd. is an investment company that is not classified elsewhere. | Finance |
- Bourse
- Insiders
- Michael Monsour
- Expérience